PetVivo receives $200K on partial option exercise; extends Series B preferred offering option to June 26

PetVivo Holdings, Inc.

Received $200,000 on May 6, 2025 from partial exercise of Purchase Option under March 26 Subscription Agreement.
Purchase Option extended 30 days to June 26, 2025 for up to $4.2M remaining of $5M Series B Convertible Preferred offering.
Shares priced at $1.00 each; investor represented as accredited; securities unregistered and restricted.
Proceeds intended for commercialization of Spryng™, PrecisePRP, clinical trials, and working capital.
Option allows purchase of up to 4,400,000 additional shares at same terms; no minimum offering amount.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.